What to Know About Berobenatide, Pfizer's Experimental Obesity Drug

What to know about berobenatide, Pfizer's experimental obesity drug

Berobenatide injections would only need to be taken 12 times a year rather than 52 with weekly injections.

The next goal for weight loss drugs? Fewer injections

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.

Why are GLP-1 drugs moving toward monthly shots?

Pfizer and Amgen point to monthly GLP 1 dosing Recent reporting indicates that the next frontier for weight loss medications is not only more weight reduction, but fewer injections . Pfizer and Amgen are developing monthly GLP 1 shots , reflecting a push to make long term use easier for patients…